{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T07:26:19Z","timestamp":1768807579318,"version":"3.49.0"},"reference-count":6,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","mayoclinicproceedings.org","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.mayocp.2021.04.002","type":"journal-article","created":{"date-parts":[[2021,6,2]],"date-time":"2021-06-02T00:55:07Z","timestamp":1622595307000},"page":"1682-1684","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Ocular Toxicity Associated With Pentosan Polysulfate Sodium"],"prefix":"10.1016","volume":"96","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7264-4265","authenticated-orcid":false,"given":"Konstantin V.","family":"Astafurov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie J.","family":"Bakri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2666-3828","authenticated-orcid":false,"given":"Andrew J.","family":"Barkmeier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.mayocp.2021.04.002_bib1","first-page":"540","article-title":"Prevalence of symptoms of bladder pain syndrome\/interstitial cystitis among adult females in the United States","volume":"186","author":"Berry","year":"2011","journal-title":"J\u00a0Urol"},{"issue":"6","key":"10.1016\/j.mayocp.2021.04.002_bib2","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.ophtha.2020.01.017","article-title":"Prevalence of maculopathy associated with long-term pentosan polysulfate therapy","volume":"127","author":"Vora","year":"2020","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1016\/j.mayocp.2021.04.002_bib3","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.ophtha.2018.04.026","article-title":"Pigmentary maculopathy associated with chronic exposure to pentosan polysulfate sodium","volume":"125","author":"Pearce","year":"2018","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.mayocp.2021.04.002_bib4","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jcjo.2019.12.001","article-title":"Pentosan-associated maculopathy: prevalence, screening guidelines, and spectrum of findings based on prospective multimodal analysis","volume":"55","author":"Wang","year":"2020","journal-title":"Can J Ophthalmol"},{"issue":"4","key":"10.1016\/j.mayocp.2021.04.002_bib5","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.ophtha.2019.10.036","article-title":"Pentosan polysulfate sodium exposure and drug-induced maculopathy in commercially insured patients in the United States","volume":"127","author":"Ludwig","year":"2020","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.mayocp.2021.04.002_bib6","doi-asserted-by":"crossref","first-page":"10","DOI":"10.5489\/cuaj.6401","article-title":"Possible drug-induced, vision-threatening maculopathy secondary to chronic pentosan polysulfate sodium (Elmiron\u00ae) exposure","volume":"14","author":"Doiron","year":"2020","journal-title":"Can Urol Assoc J"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619621003128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619621003128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T23:10:01Z","timestamp":1622761801000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619621003128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":6,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S0025619621003128"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2021.04.002","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ocular Toxicity Associated With Pentosan Polysulfate Sodium","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2021.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Mayo Foundation for Medical Education and Research","name":"copyright","label":"Copyright"}]}}